Clinical Trials Logo

Urinary Incontinence clinical trials

View clinical trials related to Urinary Incontinence.

Filter by:

NCT ID: NCT03543995 Completed - Spina Bifida Clinical Trials

The Relationship Between Nocturnal Enuresis And Spina Bifida Occulta

Start date: January 1, 2017
Phase:
Study type: Observational [Patient Registry]

It is claimed that SBO may be responsible for bladder dysfunction in patients without known neurological disease. Subsequently, it was reported that the frequency of SBO in NE cases was higher than normal children. However, in controlled trials, SBO frequency was not different in NE patients compared to the normal population. Conversely, the incidence of dysfunctional bladder in the presence of SBO in NE patients was found to be higher and the response to treatment was worse than in non-SBO patients. The present study aimed to determine whether the frequency of SBO in patients with NE was higher than in healthy subjects, the effect of SBO on the severity of LUTS and whether treatment response of primary NE patients changed in the presence of SBO.

NCT ID: NCT03543566 Recruiting - Fecal Incontinence Clinical Trials

Bladder Antimuscarinic Medication and Accidental Bowel Leakage

BAMA
Start date: June 2018
Phase:
Study type: Observational

This observational research study will examine whether a medication known as darifenacin (Enablex ®) used for urgency urinary incontinence (UUI) also helps to improve fecal incontinence symptoms. Darifenacin is FDA approved for UUI, but is not FDA approved for fecal incontinence or specifically for dual incontinence (treatment of urinary incontinence and fecal incontinence at the same time). If participants are eligible for this study, they will have had symptoms of bothersome urgency urinary incontinence and fecal incontinence, and have decided to try medication for urgency urinary incontinence. Darifenacin (Enablex ®) is an oral medication which relaxes the bladder muscle to help prevent urgency urinary leakage. It is commonly used to treat overactive bladder and urgency urinary leakage. There is some evidence that this medication may also help with fecal incontinence by slowing the gut and preventing loose stools. Investigators are planning to enroll approximately 30 patients who have both UUI and fecal incontinence and who choose medical treatment as a part of their standard care.

NCT ID: NCT03539107 Not yet recruiting - Clinical trials for Urinary Incontinence

Voiding Assessment Based on Minimum Spontaneous Void of 150 mL Compared to Retrograde Fill Method After Female Pelvic Floor Reconstructive Surgery

Start date: June 2018
Phase: N/A
Study type: Interventional

This study will compare voiding assessment based on a minimum spontaneous voided volume of 150 cc with the standard retrograde fill approach in women after pelvic floor procedures.

NCT ID: NCT03536923 Completed - Clinical trials for Stress Urinary Incontinence

Use of the Leva Incontinence System in Treating Bladder Incontinence.

Start date: April 10, 2017
Phase: N/A
Study type: Interventional

This open-label proof-of-concept study is designed to evaluate the impact of the leva digital incontinence system on the treatment of stress and mixed urinary incontinence in women over a six week period. Subjects will participate in a 2.5 minute exercise program twice daily (performed at a clinic with therapist assistance 5x weekly, and at home once daily on weekdays and twice daily on weekends. Validated surveys (UDI-6, IIQ-7 and PGI-I) will be used to evaluate symptom relief. A battery of pelvic floor muscle exercises will be performed weekly to evaluate progress in muscle strengthening.

NCT ID: NCT03536221 Not yet recruiting - Clinical trials for Urinary Incontinence

What is the Prevalence of Female Pelvic Floor Disorders in Minnesota?

Start date: August 2018
Phase:
Study type: Observational

To determine the prevalence of pelvic organ prolapse and urinary incontinence among women in Minnesota using a short web-based self-administered questionnaire.

NCT ID: NCT03535857 Recruiting - Clinical trials for Overactive Bladder Syndrome

Effectiveness of Bilateral PTNS Compared to Unilateral PTNS for the Treatment of Overactive Bladder/Urge Incontinence

BUTTON
Start date: April 17, 2018
Phase: Phase 4
Study type: Interventional

This study is designed to evaluate whether bilateral Posterior Tibial Nerve Stimulation is more effective than unilateral Posterior Tibial Nerve Stimulation at treating overactive bladder and urge urinary incontinence

NCT ID: NCT03524339 Not yet recruiting - Clinical trials for Pelvic Organ Prolapse

Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery

Start date: June 2018
Phase: Phase 2/Phase 3
Study type: Interventional

This is a placebo controlled randomized controlled trial of perioperative use of tamsulosin to prevent postoperative urinary retention in female pelvic reconstructive surgery.

NCT ID: NCT03523091 Not yet recruiting - Overactive Bladder Clinical Trials

OnabotulinumtoxinA Bladder Injection Study

Start date: June 2018
Phase: Phase 4
Study type: Interventional

Patients with overactive bladder (OAB) will be randomly assigned (like a flip of a coin) to receive 100 units of onabotulinumtoxinA injected into the bladder at either 3 sites or 10 sites. Patient satisfaction and the effectiveness of the medication will be evaluated.

NCT ID: NCT03522961 Not yet recruiting - Clinical trials for Urinary Incontinence

Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery

Start date: July 9, 2018
Phase: N/A
Study type: Interventional

We aim to compare the effectiveness of cranberry capsules versus nitrofurantoin prophylaxis in preventing urinary tract infections (UTIs) after urogynecologic surgery by conducting a double-blinded randomized clinical trial involving women with pelvic organ prolapse and/or urinary incontinence scheduled to have surgery with the Urogynecologists who comprise the Brigham and Women's Urogynecology Group.

NCT ID: NCT03522818 Recruiting - Enuresis, Nocturnal Clinical Trials

Enuresis Alarm - Is a Manual Trigger System Beneficial?

Start date: March 9, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate whether the bedwetting alarm trigger activated by parents to wake their child, in addition to the moisture alarm, will improve treatment success compared to the moisture alarm alone.